Related changes

Jump to navigation Jump to search

Enter a page name to see changes on pages linked to or from that page. (To see members of a category, enter Category:Name of category). Changes to pages on your Watchlist are in bold.

Recent changes options Show last 50 | 100 | 250 | 500 changes in last 1 | 3 | 7 | 14 | 30 days
Hide registered users | Hide anonymous users | Hide my edits | Hide bots | Hide minor edits
Show new changes starting from 04:58, 29 June 2024
   
Page name:
List of abbreviations:
N
This edit created a new page (also see list of new pages)
m
This is a minor edit
b
This edit was performed by a bot
(±123)
The page size changed by this number of bytes

27 June 2024

 m   20:15  Rituximab (Rituxan)‎ diffhist -13‎ Jwarner talk contribs
 m   20:11  Vadastuximab talirine (SGN-CD33A)‎ diffhist -14‎ Jwarner talk contribs
 m   18:27  Lenalidomide (Revlimid)‎ diffhist -6‎ Jwarner talk contribs
 m   18:21  Entospletinib (GS-9973)‎ diffhist +148‎ Jwarner talk contribs
 m   01:40  Midostaurin (Rydapt)‎ diffhist -8‎ Jwarner talk contribs
 m   00:55  Veltuzumab (hA20)‎ diffhist -7‎ Jwarner talk contribs
     00:46  Imetelstat (Rytelo)‎ diffhist -76‎ Warner-admin talk contribs
     00:45  Imatinib (Gleevec)‎ diffhist -8‎ Warner-admin talk contribs
     00:45  Idelalisib (Zydelig)‎ diffhist -6‎ Warner-admin talk contribs
     00:44  Ibrutinib (Imbruvica)‎ diffhist -14‎ Warner-admin talk contribs

26 June 2024

 m   23:34  Epcoritamab (Epkinly)‎ diffhist +276‎ Jwarner talk contribs
 m   01:44  Fostamatinib (Tavalisse)‎ diffhist -3‎ Jwarner talk contribs
 m   01:43  Fluorouracil (5-FU)‎ diffhist +1‎ Warner-admin talk contribs Text replacement - "http://en.wikipedia.org" to "https://en.wikipedia.org"
 m   01:43  Ibrutinib (Imbruvica)‎ diffhist +1‎ Warner-admin talk contribs Text replacement - "http://en.wikipedia.org" to "https://en.wikipedia.org"
 m   01:43  Acalabrutinib (Calquence)‎ diffhist +1‎ Warner-admin talk contribs Text replacement - "http://en.wikipedia.org" to "https://en.wikipedia.org"
 m   01:43  Obinutuzumab (Gazyva)‎ diffhist +1‎ Warner-admin talk contribs Text replacement - "http://en.wikipedia.org" to "https://en.wikipedia.org"
 m   01:43  Cobimetinib (Cotellic)‎ diffhist +2‎ Warner-admin talk contribs Text replacement - "http://en.wikipedia.org" to "https://en.wikipedia.org"
 m   01:42  Trametinib (Mekinist)‎ diffhist +2‎ Warner-admin talk contribs Text replacement - "http://en.wikipedia.org" to "https://en.wikipedia.org"

25 June 2024

 m   13:55  Adagrasib (Krazati)‎ diffhist +369‎ Jwarner talk contribs

21 June 2024

 m   23:48  Bevacizumab-adcd (Vegzelga)‎ diffhist +10‎ Jwarner talk contribs →‎Also known as
 m   23:47  Bevacizumab-maly (Alymsys)‎ diffhist +9‎ Jwarner talk contribs →‎Also known as
N    23:42  Bevacizumab-tnjn (Avzivi)‎ diffhist +4,211‎ Jwarner talk contribs Created page with "'''Note: this is an FDA-approved biosimilar. The information below is reproduced from the Bevacizumab (Avastin) page, except for the details of FDA indication and the refe..."
 m   21:42  Afamitresgene Autoleucel (ADP-A2M4)‎ diffhist -4‎ Jwarner talk contribs →‎Liposarcoma

18 June 2024

 m   14:15  Imatinib (Gleevec)‎ diffhist +15‎ Jwarner talk contribs →‎Also known as
  m   14:08  Crizotinib (Xalkori)‎‎ 2 changes history +20‎ [Jwarner‎ (2×)]
 m   
14:08 (cur | prev) +11‎ Jwarner talk contribs →‎Also known as
 m   
14:07 (cur | prev) +9‎ Jwarner talk contribs →‎Also known as
 m   10:54  Pembrolizumab (Keytruda)‎‎ 2 changes history +220‎ [Jwarner‎ (2×)]
 m   
10:54 (cur | prev) -2‎ Jwarner talk contribs
 m   
10:53 (cur | prev) +222‎ Jwarner talk contribs →‎Endometrial cancer
 m   00:12  Lisocabtagene maraleucel (Breyanzi)‎ diffhist 0‎ Jwarner talk contribs →‎History of changes in FDA indication

15 June 2024

 m   00:38  Blinatumomab (Blincyto)‎ diffhist +322‎ Jwarner talk contribs
  m   00:29  Durvalumab (Imfinzi)‎‎ 3 changes history +314‎ [Jwarner‎ (3×)]
 m   
00:29 (cur | prev) 0‎ Jwarner talk contribs
 m   
00:27 (cur | prev) +53‎ Jwarner talk contribs
 m   
00:25 (cur | prev) +261‎ Jwarner talk contribs →‎History of changes in FDA indication

13 June 2024

 m   21:26  Repotrectinib (Augtyro)‎ diffhist +444‎ Jwarner talk contribs →‎History of changes in FDA indication

12 June 2024

 m   23:00  Selpercatinib (Retevmo)‎ diffhist +354‎ Jwarner talk contribs →‎Thyroid cancer

11 June 2024

 m   14:34  Gefitinib (Iressa)‎ diffhist +9‎ Jwarner talk contribs →‎Also known as
  m   14:23  Erlotinib (Tarceva)‎‎ 7 changes history +65‎ [Jwarner‎ (7×)]
 m   
14:23 (cur | prev) +9‎ Jwarner talk contribs →‎Also known as
 m   
14:23 (cur | prev) +10‎ Jwarner talk contribs →‎Also known as
 m   
14:23 (cur | prev) +11‎ Jwarner talk contribs →‎Also known as
 m   
14:22 (cur | prev) +10‎ Jwarner talk contribs →‎Also known as
 m   
14:22 (cur | prev) +8‎ Jwarner talk contribs →‎Also known as
 m   
14:21 (cur | prev) +8‎ Jwarner talk contribs →‎Also known as
 m   
14:21 (cur | prev) +9‎ Jwarner talk contribs →‎Also known as

3 June 2024

 m   23:15  Mirvetuximab soravtansine (Elahere)‎ diffhist +17‎ Jwarner talk contribs →‎History of changes in FDA indication

1 June 2024

 m   04:10  Luspatercept (Reblozyl)‎ diffhist +179‎ Jwarner talk contribs
 m   04:09  Talazoparib (Talzenna)‎ diffhist +404‎ Jwarner talk contribs
  m   04:07  Trametinib (Mekinist)‎‎ 2 changes history +461‎ [Jwarner‎ (2×)]
 m   
04:07 (cur | prev) +70‎ Jwarner talk contribs
 m   
04:06 (cur | prev) +391‎ Jwarner talk contribs →‎History of changes in PMDA indication
 m   04:06  Dabrafenib (Tafinlar)‎‎ 2 changes history +461‎ [Jwarner‎ (2×)]
 m   
04:06 (cur | prev) +70‎ Jwarner talk contribs
 m   
04:05 (cur | prev) +391‎ Jwarner talk contribs →‎History of changes in PMDA indication
Retrieved from "https://hemonc.org/wiki/Special:RecentChangesLinked"